widely perceived to be harmful, if not
bothersome. Additionally, VOC content
is highly flammable, so any grinding or
open-flame operations must halt during
installation. Due to these factors, demand
for VOC-free products that do not contain
formaldehyde has increased, as these
options reduce off-gassing odors and
installation delays related to open-flame
activities. As an example, Sika’s flooring
systems comply with AFSSET COMPLY
and AgBB requirements regarding VOC
emissions of construction products.
CONSULT THE EXPERTS
The first step to designing any
flooring system is to assess a facility’s
needs. Working with a seasoned
team with years—if not decades—of
experience in designing and installing
systems for pharmaceutical labs,
R&D, production or manufacturing
applications is a good first step.
Architects, designers and managers of
pharmaceutical facilities work with
networks of technical, design and
construction experts to create systems
that address the unique demands
of pharmaceutical environments.
Installation partners work closely
with companies to shave weeks off
construction and allow pharmaceutical
manufacturers to mitigate delays in
production and costs associated with
shutdowns—because asserting greater
control over life sciences facilities should
start from the floor up.
Jim Hendley is Vertical Market
Manager, Life Sciences, with Sika Corp.,
a specialty chemicals company that
develops and produces systems and
products for bonding, sealing, damping,
reinforcement and protection in the
building sector and automotive industry.
Sika has subsidiaries in 100 countries
around the world and manufactures in
over 190 factories. usa.sika.com
Sika has engineered a line of systems specifically designed to meet pharmaceutical floor and wall regulations for physical properties including, slip, chemical and impact
resistances. Image: Sika Corp.